# IntraCranial Angiography-derived Fraction Flow-guided Percutaneous Transluminal Angioplasty and Stenting Versus Medical Therapy (ICAS-MT)

> **NCT05974033** · NA · NOT_YET_RECRUITING · sponsor: **Changhai Hospital** · enrollment: 536 (estimated)

## Conditions studied

- ICAS - Intracranial Atherosclerosis

## Interventions

- **COMBINATION_PRODUCT:** Stenting plus medical therapy
- **DRUG:** Medical therapy alone

## Key facts

- **NCT ID:** NCT05974033
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-08
- **Primary completion:** 2025-12
- **Final completion:** 2027-12
- **Target enrollment:** 536 (ESTIMATED)
- **Last updated:** 2023-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05974033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05974033, "IntraCranial Angiography-derived Fraction Flow-guided Percutaneous Transluminal Angioplasty and Stenting Versus Medical Therapy (ICAS-MT)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05974033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*